Skip to main content

Table 1 Selected characteristics of the EPICAP study population (N = 1693)

From: Occupation and prostate Cancer risk: results from the epidemiological study of prostate cancer (EPICAP)

Characteristics

Cases

n = 818 (%)

Controls

n = 875 (%)

p-value*

Gleason score at diagnosis

 

  ≤ 7

623 (77.4)

  ≥ 7††

182 (22.6)

Age

0.150

  < 55 years

48 (5.9)

59 (6.7)

 55–59 years

99 (12.1)

99 (11.3)

 60–64 years

216 (26.4)

200 (22.9)

 65–69 years

274 (33.5)

283 (32.3)

  ≥ 70 years

181 (22.1)

234 (26.8)

Ethnic origin

0.402

 Caucasian,

794 (97.1)

855 (97.7)

 Others

24 (2.9)

20 (2.3)

First-degree family history of prostate cancer

< 0.001

 no

548 (75.2)

722 (90.5)

 yes

181 (24.8)

76 (9.5)

Educational level

0.503

 none

70 (8.5)

71 (8.1)

 primary school

376 (46.0)

434 (49.7)

 high school

112 (13.7)

109 (12.5)

 university

260 (31.8)

260 (29.7)

Marital status

0.193

 married/domestic partnership

674 (82.4)

748 (85.5)

 divorced/separated/single

115 (14.1)

98 (11.2)

 widowed

29 (3.5)

29 (3.3)

Smoking status

0.362

 non-smokers

240 (29.4)

246 (28.1)

 former smokers

454 (55.6)

475 (54.3)

 current smokers

123 (15.0)

154 (17.6)

Regular alcohol drinking

0.576

 no

72 (8.8)

84 (9.6)

 yes

744 (91.2)

790 (90.4)

Intensity of physical activity

0.123

  < 1 h/week

191 (23.5)

177 (20.3)

 lifetime MET between 0.10–6.23

153 (18.8)

172 (19.8)

 lifetime MET between 6.25–13.01

133 (16.4)

172 (19.8)

 lifetime MET between 13.07–24.11

149 (18.3)

175 (20.1)

 lifetime MET between 24.15–351.40

187 (23.0)

174 (20.0)

Waist circumference (in centimetres)

0.082

  ≤ 94

208 (25.8)

253 (29.6)

  > 94

599 (74.2)

602 (70.4)

Body-mass index 2 years before diagnosis or interview, in kg/m2

0.862

  < 25

296 (36.7)

314 (36.5)

 25–29

377 (46.7)

394 (45.9)

  ≥ 30

134 (16.6)

151 (17.6)

Night shift work

0.522

 never

532 (65.0)

556 (63.5)

 ever

286 (35.0)

319 (36.5)

Last screening for prostate cancer before interview, in years

 

  ≤ 2

606 (75.2)

  > 2

66 (8.2)

Never screened

134 (16.6)

  1. Abbreviations. *p-value: Chi-2 test;  ≤ 7(3 + 4): low aggressive cancer; †† ≥ 7 (4 + 3): high aggressive cancer; MET Metabolic Equivalent of Task